The U.S. saw more than 600,000 adolescents ages 12 to 15 roll up their sleeves to receive the Pfizer-BioNTech COVID-19 vaccine following the recently expanded FDA emergency use authorization.
The U.S. saw more than 600,000 adolescents ages 12 to 15 roll up their sleeves to receive the Pfizer-BioNTech COVID-19 vaccine following the recently expanded FDA emergency use authorization.
